The issue affected about 3 million Libre 3 and Libre 3 Plus sensors in the U.S. and globally Abbott has received reports of 736 serious health problems (57 in the U.S.) and seven deaths (none in the U ...

Cuffless devices to measure blood pressure, such as smartwatches, rings, patches and fingertip monitors, show great promise ...

About 3 million glucose monitoring sensors were potentially affected by a production error that caused incorrect low glucose ...

A needle-free glucose sensor developed by a Monmouthshire business is offering new hope to people living with diabetes.

Dexcom has been hit by a major safety issue for an Android version of its G6 continuous glucose monitoring system app, leading the FDA to issue its most serious recall notice. A “software defect in ...

A recent investigation by Hunterbrook alleged that Dexcom "dropped the ball" in ensuring the accuracy and reliability of its G7 glucose monitoring device. Some patients reportedly experienced severe ...

People with Type 1 diabetes are estimated to make up to 180 more decisions a day than someone without the disease, according to a study from Stanford University. Each meal, workout, or night’s sleep ...

Continuous glucose monitors — tiny sensors once reserved for people with diabetes — are now appearing on the arms of runners, nutrition enthusiasts, and wellness influencers. As the devices have ...

This diabetes technology offers a continuous stream of data to show a more complete picture of your blood sugars over time. This is different from a fingerstick meter that only represents that moment.

As the health and fitness editor at CNN Underscored, I’m no stranger to testing wearables like running watches and Oura rings. So when I first heard about Lingo, Abbott’s continuous glucose monitor ...

Oct 21 (Reuters) - Walmart (WMT.N), opens new tab will become the first U.S. retailer to sell Abbott Laboratories' (ABT.N), opens new tab over-the-counter continuous glucose monitor Lingo in physical ...

Walmart will become the first U.S. retailer to sell Abbott’s continuous glucose monitoring device as the medtech giant looks to broaden its sales potential for its growing business unit. Abbott has ...